Robeco Institutional Asset Management’s Corcept Therapeutics CORT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,107
| Closed | -$355K | – | 878 |
|
2025
Q1 | $355K | Buy |
+3,107
| New | +$355K | ﹤0.01% | 855 |
|
2024
Q4 | – | Sell |
-6,436
| Closed | -$298K | – | 907 |
|
2024
Q3 | $298K | Sell |
6,436
-12,805
| -67% | -$593K | ﹤0.01% | 868 |
|
2024
Q2 | $625K | Sell |
19,241
-2,467
| -11% | -$80.2K | ﹤0.01% | 820 |
|
2024
Q1 | $547K | Sell |
21,708
-10,299
| -32% | -$259K | ﹤0.01% | 825 |
|
2023
Q4 | $1.04M | Buy |
32,007
+11,545
| +56% | +$375K | ﹤0.01% | 778 |
|
2023
Q3 | $557K | Hold |
20,462
| – | – | ﹤0.01% | 833 |
|
2023
Q2 | $455K | Sell |
20,462
-10,797
| -35% | -$240K | ﹤0.01% | 867 |
|
2023
Q1 | $677K | Hold |
31,259
| – | – | ﹤0.01% | 819 |
|
2022
Q4 | $635K | Buy |
31,259
+6,809
| +28% | +$138K | ﹤0.01% | 815 |
|
2022
Q3 | $626K | Sell |
24,450
-4,512
| -16% | -$116K | ﹤0.01% | 750 |
|
2022
Q2 | $689K | Buy |
28,962
+291
| +1% | +$6.92K | ﹤0.01% | 731 |
|
2022
Q1 | $645K | Hold |
28,671
| – | – | ﹤0.01% | 748 |
|
2021
Q4 | $567K | Hold |
28,671
| – | – | ﹤0.01% | 758 |
|
2021
Q3 | $564K | Hold |
28,671
| – | – | ﹤0.01% | 763 |
|
2021
Q2 | $631K | Sell |
28,671
-10,511
| -27% | -$231K | ﹤0.01% | 778 |
|
2021
Q1 | $932K | Sell |
39,182
-10,596
| -21% | -$252K | ﹤0.01% | 738 |
|
2020
Q4 | $1.3M | Sell |
49,778
-6,513
| -12% | -$170K | ﹤0.01% | 708 |
|
2020
Q3 | $981K | Buy |
56,291
+12,538
| +29% | +$219K | ﹤0.01% | 715 |
|
2020
Q2 | $736K | Hold |
43,753
| – | – | ﹤0.01% | 771 |
|
2020
Q1 | $520K | Buy |
43,753
+21,782
| +99% | +$259K | ﹤0.01% | 811 |
|
2019
Q4 | $266K | Hold |
21,971
| – | – | ﹤0.01% | 882 |
|
2019
Q3 | $310K | Buy |
+21,971
| New | +$310K | ﹤0.01% | 866 |
|
2018
Q2 | – | Sell |
-17,624
| Closed | -$290K | – | 964 |
|
2018
Q1 | $290K | Hold |
17,624
| – | – | ﹤0.01% | 848 |
|
2017
Q4 | $318K | Hold |
17,624
| – | – | ﹤0.01% | 804 |
|
2017
Q3 | $340K | Hold |
17,624
| – | – | ﹤0.01% | 749 |
|
2017
Q2 | $208K | Buy |
+17,624
| New | +$208K | ﹤0.01% | 804 |
|